Medicure Inc. (OTCMKTS:MCUJF – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.74 and traded as low as $0.60. Medicure shares last traded at $0.60, with a volume of 5,000 shares.
Medicure Price Performance
The company has a current ratio of 2.03, a quick ratio of 1.64 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $6.21 million, a PE ratio of -4.25 and a beta of 0.98. The firm has a 50-day moving average of $0.66 and a two-hundred day moving average of $0.73.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Articles
- Five stocks we like better than Medicure
- Airline Stocks – Top Airline Stocks to Buy Now
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- How to Calculate Inflation Rate
- Top 3 ETFs to Hedge Against Inflation in 2025
- What Are Dividend Achievers? An Introduction
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
